the shape of the curve should be taken with some reservation, particularly
since Later tests with more refined dosimetric methods (which in this particular instance left something to be desired) gave more nearly linear doseeffect relationships.

63.

In the Greenhouse series [U5] the Gompertz plot of irradiated mice showed

a displacement upwards and to the left of the control curves in both sexes.
Life-span-shortening was reported to be due to premature onset of all diseases

observed in normal aging mice.

The onset of old-age diseases was advanced to

essentially the same extent by any one dose, an exception being thymic lymphoma
whose incidence was greatly increased in both sexes.

There was no consistent

relationship between frequency of neoplasia and dose, because the incidence of
some tumours (thymic lymphoma, granulocytic leukaemia, tumours of the ovary)
increased but that of others

with increasing doses.

(reticulum cell sarcoma, mammary sarcoma)

decreased

Thus, no overall clear-cut relationship could be estab-

lished between life-span-shortening and tumour incidence.

6h.

Some of the data from the Greenhouse experiment (male and female ani-

mals receiving up to 267 rad) were reanalised by Walburg [W1] on the basis
of the original pathology data and with appropriate corrections for competing

probabilities of death [H2, H4].

A significant life-shortening effect was

observed when all causes of death were considered together; but when only non-

neoplastic deaths were taken into account there was no advancement in time of

mortality due to these diseases.

Walburg concluded therefore that evidence

of life~shortening due to non-neoplastic causes was lacking, although these
experiments are often cited as an example of non-specific life-shortening.

65.

Working on six mouse strains irradiation with single doses of x razs

around the LD
with dose.

3 Grahn [Gh] reported a curvilinear type of relationship

oeaperopriate eorrection for animals dying of leukaemia and ova-

rian tumours he was able to eliminate much of the variability between strains
and sexes and to reconduct the whole process culminating in life-shortening

to a basic injury parameter (0.28 days of life lost/R or 19 per cent life lost

for irradiation at the LD

)

applying to all strains and sexes.

On this

50/30
basic parameter other factors, specific for life-shortening due to leukaemia
and ovarian tumours, would superimpose to give predictable amounts of effect
at any dose and for any strain and sex.

Jordan !Vi] are summarized in Table 2.

Other data by Vogel, Frigerio and

Select target paragraph3